Monetary Management Group Inc Biogen Inc. Transaction History

Monetary Management Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $382,025 - $611,697	-1,475 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $348,483 - $524,554	1,475 New	1,475 $361,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $672,125 - $852,600	-2,500 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $573,256 - $792,102	-2,605 Reduced 51.03%	2,500 $742,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $16,308 - $18,291	-75 Reduced 1.45%	5,105 $1.19 Million
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $578,925 - $638,140	2,640 Added 103.94%	5,180 $1.21 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $550,443 - $860,958	2,540 New	2,540 $600,000
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $52,026 - $73,582	-200 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $7,691 - $8,614	-25 Reduced 11.11%	200 $64,000
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $147,603 - $173,087	-525 Reduced 70.0%	225 $70,000
Q2 2017 Aug 14, 2017	BUY	N/A	750	750 $204,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

Stay updated on Monetary Management Group Inc with notifications on news.